Filing step-change
TAMBOLIIN · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
Tamboliin Sees Sharply Improving Gross Margin and Marginal Operating Leverage Tamboliin's 85.7% gross margin accelerated to, up from 14.32% in the latest quarter.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 85.7 % | 14.32 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 14.32 % | 12.93 | ▲ |
| REVENUE_GROWTH_YOY | 10.3 % | 64.8 | ▼ |
Cite this
Source: Samhati filing step-change for TAMBOLIIN (2026-09). Observation: Tamboliin Sees Sharply Improving Gross Margin and Marginal Operating Leverage Tamboliin's 85.7% gross margin accelerated to, up from 14.32% in the latest quarter. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/tamboliin/q/2026-09
Other periods